Insta
Bharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)
Dr Krishna Ella-led vaccine maker Bharat Biotech is likely to begin the trial of indigenously developed COVID-19 vaccine Covaxin for those below the age of 18 years and older than two years by end of February or early March, reports Times of India.
A leading children's hospital in Nagpur is said to have been earmarked as one of the sites for the trials which would begin as soon as the Hyderabad based vaccine maker gets the Government's regulatory go ahead.
As per the coordinator for the trials, Dr Ashish Tajne, the trial would be the first in the world in which a COVID-19 vaccine's trials would be conducted on paediatric population from toddlers to teens. He also shared that the trials will be conducted in age slabs like two to five years, six to 12 years, and 12 to 18 years.
It should be noted that Dr Ella who is the chairman and managing director of Bharat Biotech had said in January that the vaccine for children will be ready in the next four months.
The development gains significance as the international regulations state that only the vaccines based on the inactivated virus can be administered to children under the age of 16 years. This makes Bharat Biotech's Covaxin the only suitable option for children in India given the other Made in India vaccines are based on mRNA technology and chimpanzee adenovirus vector platforms.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest